Merck Steps Up As AiCuris’ First Development Partner

 
• By Jessica Merrill

Merck partners with on AiCuris on letermovir and other antiviral candidates for human cytomegalovirus (HCMV), marking the first development deal for the German drug developer, spun out from Bayer in 2006.

More from Archive

More from Pink Sheet